The cost per cancer detected for prostate screening for age-groups 50-59, 60-69 and 50-69 were $2,953, $2,137 and $2,372 respectively in the multicentre study, and $2,205 in the single centre study (age 50-70). In one of the studies, the cost per cancer detected for breast cancer for the same age-groups were $15,490, $8,018 and $10,975 respectively; in other study it was $15,284 (age group 50-59).
In terms of the impact of cancer screening on patient morbidity, prostate cancer screening would be equally cost-effective to breast cancer screening if it improved prostate cancer mortality by only 5.7% to 8.1%.